Antiplatelet Therapy In Ischemic Heart Disease
Erschienen am 26. Januar 2009
312 Seiten
978-1-4443-0334-6 (ISBN)
Beschreibung
This book in the new American Heart Association ClinicalSeries, explores and explains state-of-the-art use ofantiplatelet agents and draws on the expertise of global leaders inantiplatelet therapy. Skillfully organized for fast reference, thebook is divided into five parts:
* * Concepts in Platelet Physiology, Function, andMeasurement
* Pharmacology of Oral Antiplatelet Agents
* Pharmacology of Intravenous Antiplatelet Agents
* Clinical Use of Antiplatelet Agents in CardiovascularDisease
* Special Circumstances.
Each chapter in the clinical section contains an overview ofguidelines, plus specifics on medical and interventionaluses.
Clinical cardiologists, platelet biologists, and a wide range ofpracticing and prospective clinicians in allied fields will findthis text an exceptional source of current information.
Rezensionen / Stimmen
"This thorough book addresses the topic in a concise manner. It can be used as a quick reference by busy practitioners or as a teaching guide for students." (Doody's Reviews, June 2009)Weitere Details
Weitere Ausgaben
Person
Stephen D. Wiviott, MD., Investigator TIMI Study Group,Associate Physician,
Cardiovascular Division, Brigham and Women's Hospital,Harvard Medical School, Boston, MA, USA
Inhalt
Part I Concepts in Platelet Physiology, Function andMeasurement.
1 Platelet physiology and the role of the platelet in ischemicheart disease.
Robert F. Storey .
2 Laboratory assessment of platelet function and the effects ofantiplatelet agents.
Alan D. Michelson, A.L. Frelinger .
Part II Pharmacology of Oral Antiplatelet Agents.
3 Cyclooxygenase inhibitors.
Nina Chetty Raju, John W. Eikelboom .
4 Aspirin response variability and resistance.
Wai-Hong Chen, Daniel I. Simon .
5 P2Y12 inhibitors: Thienopyridines and direct oralinhibitors.
Jean-Philippe Collet, Boris Aleil, Christian Gachet, GillesMontalescot .
6 Thienopyridine response variability and resistance.
Udaya S. Tantry, Thomas A. Suarez, Paul A. Gurbel .
Part III Pharmacology of Intravenous AntiplateletAgents.
7 Pharmacology of intravenous glycoprotein IIb/IIIaantagonists.
James C. Blankenship, Peter B. Berger .
8 Intravenous P2Y12 inhibitors.
Steven P. Dunn, Steven R. Steinhubl .
9 Antiplatelet effects of thrombin inhibitors and fibrinolyticagents.
Nicolai Mejevoi, Anjum Tanwir, Marc Cohen .
Part IV Clinical Use of Antiplatelet Agents in CardiovascularDisease.
10 Antiplatelet therapy in acute coronary syndrome with STelevation.
Christian W. Hamm .
11 Antiplatelet therapy in ST-elevation myocardialinfarction.
Michelle O'Donoghue, Marc S. Sabatine .
12 Antiplatelet therapy in chronic artery disease.
Kamran I. Muhammed, Deepak L. Bhatt .
13 Antiplatelet therapy in peripheral arterial disease.
Esther S. Kim, Heather L. Gornik .
14 Clinical use of antiplatelet agents in cardiovasculardisease: cerebrovascular diseases.
Larry B. Goldstein .
Part V Special Circumstances.
15 Antiplatelet therapy and coronary bypass surgery: risks andbenefits.
A. Burdess, N.L. Cruden, K.A. Fox .
16 Management of antiplatelet therapy for non-cardiacsurgery.
Nisheeth Goel, John F. Canales, James J. Ferguson .
17 Antiplatelet therapy and coronary stents.
Alanna Coolong, Laura Mauri
